Oncology & Hematology Coding Alert

Reader Questions:

Expect Calcitonin Denial

Question: I-ve been getting denials from Medicare for calcitonin injections provided incident-to the physician's service. Why?

Alaska Subscriber  Answer: Alaska Medicare-contractor Noridian's coverage rules exclude calcitonin (J0630, Injection, calcitonin-salmon, up to 400 units) from payment because it is usually self-administered by the beneficiary. The rule only applies to outpatient drugs in the outpatient setting.

Your oncologist may have ordered the calcitonin to help a patient with bone pain from metastasis.

Tip: You don't need an advance beneficiary notice (ABN) for this procedure because you will get a -benefit category- denial, rather than a medical-necessity denial. Benefit-category denials result when there is no benefit category covering the drug. You may charge the beneficiary for the drug. Good idea: You may not need an ABN but, as a courtesy, inform the patient of his financial responsibility before administering the calcitonin.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All